ADREVIEW [123I] 74 MBq/ml, solution for injection bottle
Active ingredients: IODE [123 I], Iobenguane sulfate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ADREVIEW [123I] 74 MBq/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 74 MBq/ml
- Marketing authorisation holder
- GE HEALTHCARE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Dec 2007
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65884582CIP75644593CIP133400956445936Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IODE [123 I]solution | 74 MBq/ml à la date et à l'heure de calibration · un flacon de 1 ml | FT |
| MÉTA-IODOBENZYLGUANIDINE (SULFATE DE)solution | 0,15 mg · un flacon de 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.